Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167 | 10 | 55 | 3 | 7 |
| Receivables | 57 | 486 | 458 | 899 | 1,739 |
| TOTAL | $266 | $550 | $534 | $936 | $1,789 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $266 | $550 | $534 | $936 | $1,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,438 | 2,382 | 2,827 | 2,770 | 4,456 |
| Accounts payable and accrued liabilities | 1,255 | 1,452 | 1,461 | 2,352 | 3,017 |
| Accrued Expenses | 0 | 0 | 54 | 43 | 78 |
| TOTAL | $3,924 | $4,318 | $4,794 | $5,283 | $7,724 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 500 |
| Deferred Revenues | 0 | 0 | 0 | 118 | 0 |
| TOTAL | $0 | $0 | $0 | $0 | $500 |
| Total Liabilities | $3,924 | $4,318 | $4,794 | $5,283 | $8,224 |
| Shareholders' Equity | |||||
| Common Shares | 19,220 | 18,924 | 17,864 | 17,418 | 16,055 |
| Retained earnings | -33,254 | -33,012 | -32,388 | -31,971 | -29,983 |
| Other shareholders' equity | 2,695 | 2,695 | 2,695 | 2,695 | 0 |
| TOTAL | $-3,658 | $-3,768 | $-4,260 | $-4,348 | $-6,435 |
| Total Liabilities And Equity | $266 | $550 | $534 | $936 | $1,789 |